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Abstract: Introduction: Haemangiomas and Vascular malformations of the maxillofacial region are formidable lesions 
causing considerable cosmetic deformity and grave functional debilitation. Technically, their surgical excision is difficult 
and challenging, fraught with complications like hemorrhage, incomplete excision, facial disfigurement and recurrence. 
This study has fashioned two techniques directed at permanently treating these lesions. 
Aim: Evaluating the safety and long term efficacy of single session sclerotherapy with Polydocanol for superficial 
cutaneous / mucosal low flow vascular malformations; and of sclerothrombotic therapy with hot water as a neoadjuvant 
modality followed by surgical excision, for deeper high flow vascular malformations of the maxillofacial region.  
Methods: Ten cases of Vascular Malformations of the maxillofacial region were treated. Of them, five were superficial, 
low flow lesions which were managed using intralesional instillation of Polydocanol alone without any surgical 
intervention thereafter; and the remaining five were deep, high flow lesions, which were treated first, by intralesional 
injection of hot water over two sessions, which was then followed by surgical excision of the lesion, which was carried 
out within the next 72 hours.  
Results: Complete resolution of the lesions was achieved in all the cases. 
Conclusion: Our results support the fact that single session sclerotherapy with Polydocanol may be considered as the 
primary modality in the treatment for superficial (cutaneous or mucosal) low flow vascular malformations. However, for 
deeper, high flow lesions, two sessions of intra lesional injection of hot water followed by surgical excision within 72 
hours of the first injection, may be the treatment of choice.  
Keywords: Vascular anomalies, Vascular malformations, Haemangioma, Sclerotherapy, Polydocanol, Hot water, 
Sclerothrombosis. 
INTRODUCTION 
Vascular lesions or anomalies are a heterogeneous 
group of blood vessel disorders which, based on their 
clinical behavior and endothelial cell characteristics, 
were classified by Mulliken and Glowacki in 1982 into 
two broad categories, Vascular Tumors, also referred 
to as Haemangiomas, and Vascular Malformations 
(VMs) [1, 2]. This comprehensive classification was 
accepted and adopted by the International Society for 
the Study of Vascular Anomalies (ISSVA) in 1996. In 
2013, the ISSVA Classification was reinforced with an 
additional review on syndrome-based classification [2]. 
 Haemangiomas are true vascular neoplasms, 
usually seen in infancy and childhood, comprising of an 
increased number of normal or abnormal blood vessels 
lined with thickened subendothelial basement 
membrane laminas, and hypercellular / hyperplastic 
endothelial cells. They are characterized clinically by a 
rapid neonatal growth until the age of 6-8 months 
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(proliferative phase) and then a slow regression by the 
age of 5-10 years (involuting phase), characterized by 
diminishing cellularity, interstitial fibrosis and fibrofatty 
replacement [1]. 
Vascular malformations (VMs) on the other hand, 
are congenital lesions resulting from developmental 
anomalies due to errors in vascular and lymphatic 
morphogenesis, and comprise of abnormally formed 
channels that are lined by quiescent endothelium 
(normal endothelial cell turnover). 31% of VMs are 
found in the Head & Neck region [18]. These lesions 
are present at birth, though they often go unnoticed, 
and grow commensurately with the child with a normal 
rate of endothelial cell turnover. They increase in size 
during infancy through adolescence proportionally to 
the overall growth of the patient. Growth may also be 
triggered by trauma, infection and hormonal fluctuation 
as in puberty, pregnancy, use of oral contraceptives, 
etc. Histologically, there is no proliferative or involution 
phase and endothelial as well as mast cell activity is 
normal. Vascular channels are lined by mature 
endothelial cells which are surrounded by a normal 
reticulum and a single cell layer basement membrane 
[2]. The mechanism of growth of these lesions is not 
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increased endothelial proliferation, but alteration in the 
flow dynamics within and around the lesion resulting in 
the recruitment of collateral vessels and dilatation of 
the involved vessels.  
Lymphatic, capillary, venous, and arteriovenous 
malformations make up the majority of vascular 
malformations. They may infiltrate skin, mucosa, 
muscles, joints, organ systems and sometimes even 
bones. Symptoms are dependent on the anatomic 
location of the lesion and can have a great impact on 
the patient’s quality of life. Pain and swelling are 
common symptoms associated with VMs. With 
craniofacial lesions, cosmetic disfigurement may be 
more debilitating than functional limitations [3, 4] often 
leading to psychological stress and feelings of 
embarrassment, anxiety, low self-esteem, and 
antisocial behavior. Moreover, these lesions are often 
associated with recurrent bleeding episodes, 
secondary infections and ulcerations. From these 
perspectives, the treatment of VMs is more than just a 
cosmetic concern. 
Based on flow characteristics which are readily 
characterized by thrills, bruits and increased warmth; 
and based on USG findings and CT angiography, 
Vascular Malformations may be classified as: 
(1) Low-flow lesions 
a. Capillary malformation  
b. Venous malformation  
c. Lymphatic malformation  
d. Mixed 
(2) High-flow lesions 
a. Arterial malformation 
b. Arteriovenous malformations (AVMs) 
c. Arteriovenous fistulae (AVF) 
Conventionally, VMs have been managed surgically 
with or without embolization. The procedure is often 
cumbersome, time consuming and associated with 
technical difficulties and complications, such as 
inadvertent injury to important head and neck struc- 
tures, intraoperative bleeding and exsanguinations. 
Though newer modalities of treatment of vascular 
lesions have been added to the options available, such 
as Cryosurgery, compression, radiation, flash lamp 
pulsed laser, intralesional injection of fibrosing agents, 
interferon alpha-2b electrocoagulation and radiofrequ- 
ency ablation [5-7], laser therapy [8-10] and so on, the 
older, time tested techniques i.e. percutaneous / 
permucosal Sclerotherapy and Microembolization [11] 
are still the mainstay in the treatment of these difficult 
lesions making them more amenable to easier surgical 
excision. 
Sclerotherapy is a simple, popular, minimally 
invasive and cost effective procedure, widely used in 
the management of hemorrhoids, superficial lower 
extremity telangiectasias and venous abnormalities 
such as varicose and reticulate veins [12]. It has also 
been found to be effective in craniofacial 
haemangiomas [13]. For smaller lesions, Sclerotherapy 
by itself can lead to a complete cure, while for larger 
lesions, it may facilitate surgery by reducing lesion size 
and minimizing intraoperative blood loss [14-16]. It 
involves the direct injection of a small amount of an 
irritant solution / sclerosant into the abnormally dilated 
vessels and applying local compression to maintain the 
contact of the intravascular solution with the endothelial 
cells. Over the years, various sclerosants have been 
employed, such as sodium tetra decylsulphate, 5% 
phenol, sodium morrhuate, nitrogen mustard, boiling 
water, sodium psylliate, sodium citrate, invert sugar, 
absolute alcohol, hypertonic saline or hypertonic 
dextrose 
In our study a total of ten cases of Vascular 
Malformations (VMs) were managed. Of them, five 
were superficial, low flow VMs which were treated by a 
monotherapy technique, using intralesional 
Polydocanol sclerotherapy alone; and the remaining 
five were high flow, deep set VMs, which were treated 
by a bi-therapy technique, using neoadjuvant 
sclerothrombotic hot water instillation in two cycles, 
followed by surgical excision of the lesion.  
The aim of this study was to assess the efficacy of 
single session Polydocanol Sclerotherapy in the 
management of superficial cutaneous and mucosal 
VMs in maxillofacial region, in terms of reduction in size 
or complete resolution of the lesion, time taken for 
resolution and incidence of complications and of 
recurrence; and to assess the efficacy of hot water 
scleothrombosis followed by surgical resection in the 
management of deeper vascular malformations of the 
maxillofacial region, including incidences of 
complications and recurrence. The purpose of the 
study was to thereby, to evaluate the utility of these two 
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different management protocols for the two different 
types of VMs. 
1. METHODS 
This study was carried out at our Centre and 
included cases treated between 2010 and 2016. The 
inclusion criteria were Vascular Malformations involving 
the soft tissues of the maxillofacial region. These 
included low flow as well as high flow Vascular 
Malformations involving both superficial as well deeper 
soft tissues. Patients with other diagnoses i.e. intraoss- 
eous venous malformations and haemangiomas were 
excluded from this study. A total of ten patients (two 
male and eight females) were included in the study. 
The mean age range was from 28 to 52 years. The 
patient details are summarized as per Table 1. 
Pre-operative assessment in each of the cases 
included history and clinical presentation, aided by 
Magnetic resonance imaging study and Ultrasound 
color Doppler study of the lesions, which led to a 
provisional diagnosis of a Venous malformation in all of 
these cases. FNAC could not be carried out in any 
patient as even a mild probing gave rise to an 
immediate and ready ooze of blood. In all the patients, 
PT, pTTK and INR levels were all within normal limits 
as was the remaining blood and urine profile. The 
patients were neither diabetic nor hypertensive. 
Ultrasound Colour Doppler study was carried out in 
each case and demonstrated slow (Group A patients) 
and high flow lesions (Group B patients), consisting of 
anomalous channels suggestive of vascular 
malformations. In addition, MRI (T1 & T2 weighted 
images with Fat Suppression and Fat enhancement, 
respectively) in each case, showed a space occupying 
lesion.  
There was no randomization of allocation, but rather 
the Patients were selected and placed into two Groups, 
depending upon the presentation and characteristics of 
their VMs, such as the flow pattern, extent and depth of 
the lesions. Patients with relatively superficial 
mucosal/cutaneous, easily accessible lesions were 
placed in Group A, while those with deep set, high flow 
lesions were placed in Group B.  
Group A patients were treated by single session 
sclerotherapy using intralesional injection of 
Polydocanol in an Outpatient setting. Informed written 
consent was obtained from each patient of Group A for 
intralesional sclerotherapy using Polydocanol.  
Whenever possible, the lesion (Figure 1 A, B, C, D); 
(Figure 4 A, B) was first isolated using black braided 
silk sutures to prevent sclerosant spill, reducing its 
diffusion into adjacent unaffected tissues, and also to 
prolong its contact with the endothelial cells of the 
abnormal vascular channels (Figure 1 C, D). 
Immediately the lesion was found to become engorged 
and enlarged in size (Figure 1 C, D). 2-3cc of undiluted 
Polydocanol (2-3mg), depending upon the size of the 
lesion, was slowly injected into the sides as well as the 
center of the lesion, using 1 cc syringes, after first 
infiltrating the area with a local anesthetic. Immediately 
following the injection, the lesion swelled and became 
tense (Figure 1 E, F). A mild ooze of blood was noted 
from the permucosal / percutaneous puncture sites, 
which soon stopped after application of local pressure 
 
Figure 1: A, B A well demarcated, deep bluish - purple, 
raised, irregularly shaped, friable and pebbly surfaced patch 
on the right buccal mucosa, which was continuous with the 
buccal vestibule and its reflection into the alveolar and 
gingival mucosa in the right upper posterior quadrant. C, D 
Lesion observed to become engorged and enlarged in size 
immediately following its isolation using black braided silk 
sutures, performed to prevent sclerosant spill into the 
adjacent unaffected mucosa. E, F 3cc of undiluted 
Polydocanol (3mg) was slowly injected into the sides as well 
as the center of the lesion. 
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over the area for 3 minutes. The silk sutures were left 
in situ. The patients were put on anti-inflammatory and 
analgesic medications for five days and cold compress 
was advised externally over the region.  
All patients were followed up for a period of one to 
 
Figure 2: A, B, C, D Intraoral necrosis and sloughing of mucosal tissue at the site of sclerosant injection, and considerable local 
edema and swelling of the cheek seen after 5 days of the single session sclerotherpy. E, F, G, H By the third week, the area of 
whitish grey slough was restricted to the center of the area and the swelling of the cheek and lips had regressed. I, J, K, L 
Complete elimination and total resolution of the vascular lesion by the fourth week following the single session Sclerotherapy, 
with practically no evidence of it in the healed buccal as well as alveolar and gingival mucosae. No residual scarring or 
discoloration was evident. 
 
Figure 3: Ultrasound Colour Doppler of the right cheek performed A One month after Sclerotherapy; and B Two months after 
sclerotherapy, showing reduction in size of the hypo-echoic region as well as diminished vascularity within it, indicative of 
successful resolution of the VM.  
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five years and there was nil recurrence of the vascular 
lesions (Figure 3, 4, 5).  
Group B patients with more extensive, deeper, high 
flow lesions, were managed first by sclerothrombosis 
 
Figure 4: A, B Isolation of the VM of the upper lip followed by injection of 1cc of undiluted Polydocanol (1mg) in the center of 
the lesion. C, D One week following sclerotherpy, showing necrosis and sloughing in the region of the lesion and edema and 
swelling in the surrounding areas. E, F Reduction in the swelling, with just a healing crust remaining in the region of the lesion, 
at the end of two weeks. G, H Complete resolution and disappearance of the VM by the end of the third week.  
 
Figure 5: A, B, C VM of the nose in a 45 year old patient. D, E, F 4 weeks following Single session Sclerotherapy with 
Polydocanol, showing a complete resolution and elimination of the lesion. 
Polydocanol and Hot water Sclerothrombosis in Venous malformations World Journal of Oncology Research, 2017, Vol. 4    17 
with hot water (2 cycles, depending upon the size of 
the lesion) followed by its surgical excision under 
General Anesthesia, within 72 hours of the injection 
(Figure 6, 7). Written Informed Consent was obtained 
from each patient of Group B, for the above treatment 
protocol employed.  
RESULTS 
There was complete resolution of the vascular 
lesions in all patients in Group A as well as Group B. 
All patients were followed up for a period of one to five 
years and there was nil recurrence of the lesions, 
except in one case of Group B.  
In all the Group A patients, there was a complete 
and absolute resolution of the vascular lesion by the 
fourth week following the single session Sclerotherapy, 
with practically no evidence of the lesion following 
treatment (Figure 2 I, J, K, L; Figure 3; Figure 4 G, H). 
Successful results with this modality of treatment were 
obtained even with Cutaneous vascular malformations 
over the face (Figure 5), with complete resolution of the 
lesions.  
The imaging modalities, such as Magnetic 
Resonance Imaging and Ultrasound Colour Doppler 
were of immense value in not only in confirming the 
diagnosis, but also helped to evaluate the efficacy of 
the treatment rendered (Figure 3). 
Incidence of Complications: In all cases of Group A, 
on the fourth or fifth day following sclerosant injection, 
there was observed considerable local edema and 
swelling in the region of the lesion (Figure 2 C, D), with 
necrosis and sloughing of mucosal tissue from it 
(Figure 2 A, B). Pain was not severe and was 
effectively managed with analgesics. The patients were 
also started on a course of antibiotics. By the second 
week, the swelling, inflammation and sloughing of 
tissues began to subside and by the third week, the 
swelling had completely regressed with an area of 
whitish slough restricted to the center of the area 
(Figure 2 E, F, G, H). In some cases, just a healing 
 
Figure 6: A Middle aged female patient presented with a diffuse swelling in the Right Submandibular region. B, C CT-
Angiogram showing a vascualr lesion involving Facial and Lingual arteries. D Post Hot water injection. E, F, G Submandibular 
approach for excision of the lesion and ligation of the feeder vessels. H, I Two years Post-op appearance. J, K, L Two years 
Post-op CT Angiogram. 
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crust remained at the end of two weeks (Figure 4 E, F). 
Thereafter, healing took place completely within a 
period of one to three months, with no residual 
evidence of the lesion. 
In all patients of Group B, clinically satisfactory 
results were obtained post operatively. All patients 
were followed up from one to five years post treatment, 
and all of them remained asymptomatic with no 
evidence of recurrence, except in one patient in whom 
there was a recurrence seen in the third postoperative 
year. There were nil immediate or late post-operative 
complications. 
Histopathological examination of excised specimen 
revealed numerous irregularly dilated vascular 
channels lined by a single layer of flattened endothelial 
cells, dispersed within fibro-collagenous connective 
tissue stroma, consistent with the diagnosis of Vascular 
Malformations (Figure 7).  
 
Figure 7: A Painless, bulbous, soft swelling, 3.0x2x1.5cm in size, present since childhood, showing a recent increase in size 
over the past six months, following the use of Oral contraceptives. B 72 hours following intralesional instillation of Hot water, 
showing a decrease in size of the swelling. C, D, E Excision of the mass. F 2yrs postoperative appearance, showing no 
recurrence of the lesion. 
 
Figure 8: A, B H&E (X 200) Histopathological examination of excised specimen from lower lip. C, D H&E (X 500) Numerous 
dilated vascular channels lined by flattened endothelial cells, scattered in the fibro-collagenous Connective tissue stroma. 
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2. DISCUSSION 
Management of a VM depends on several factors, 
such as its flow characteristics, depth, location and 
anatomical site, extent of involvement and proximity of 
other structures in the region [18]. These 
characteristics dictate the choice of the treatment 
modality to be employed i.e. sclerotherapy, 
sclerothrombotic therapy, microembolism, surgery etc. 
An intralesional Sclerosant on injection, causes 
marked tissue irritation and necrosis, localized 
inflammatory reaction with swelling, disruption and 
destruction of the endothelium of the vessel wall, 
causing platelets and cellular debris to attach to the 
lining of the vessels, followed by formation of an 
intravascular coagulum leading to obliterative 
thrombosis of the blood vessel [19]. Subsequently, 
fibrosis of the vascular endothelial spaces takes place, 
eventually leading to disappearance of the treated 
vessels by histiocytic digestion, with consequent 
regression of the lesion and tissue contraction [19]. 
There are no contraindications to this modality of 
treatment other than a previous known history of 
allergic reaction to the sclerosant solution. 
Advantages of sclerotherapy are that it is a simple 
and inexpensive procedure, entailing no loss of blood, 
and that it can be carried out on an outpatient basis 
with no need for hospitalization and with a minimal 
armamentarium. Disadvantages are occasional 
anaphylactic reactions, post-operative pain and burning 
sensation, local swelling, inflammation and tissue 
necrosis, peripheral nerve injury, hemoglobinuria, 
thromboembolism, infection and delayed muscle 
fibrosis [20, 21]. Its application should always be 
carried out in the center and deeper portion of the 
lesion in order to avoid extensive tissue necrosis of 
adjacent normal areas [22]. This care was taken during 
the application of the sclerosing agent in the present 
case series.  
Boiling water sclerothrombosis acts by releasing 
heat energy that destroys the anomalous vascular 
tissues. The heat energy adversely affects the vascular 
endothelial tissues leading to disruption, necrosis and 
obliteration of the vessel’s lumina, which promotes 
coagulation of blood eventually leading to collapse and 
blockage of the channels in the anomalous 
angiomatous tissues with subsequent destruction of 
these vessels [23]. Since water has no sclerosing 
properties per se, the injection of the same heated, 
intralesionally, acts primarily due to the heat injury and 
therefore produces a much lesser inflammatory 
response of the surrounding tissues. 
In our study, five patients with superficial 
mucosal/cutaneous low flow vascular malformations, 
(placed in Group A), were managed using intralesional 
Polydocanol monotherapy injections. This sclerosant is 
a mixture of ethers, macrogols, and fatty alcohols that 
induces endothelial damage through multiple 
mechanisms. Its clinical efficacy is equivalent to 
Sodium Tetradecyl Sulfate (STS) but with less severe 
adverse effects [26]. Furthermore, due to its anesthetic 
effect, it does not cause much pain [27].  
The major issue in the management of a high flow 
VM is the difficulty in restraining the intralesional 
sclerosant / thrombotic / embolization agent within the 
lesion. The high blood flow through the lesion tends to 
flush out the sclerosant into the surrounding areas [28], 
thus reducing its efficacy and also risking collateral 
damage to the adjacent structures e.g. skin, eyes etc. 
In order to avoid these deleterious effects of agents like 
Sodium tetradecyl-sulphate and Polydocanol in the 
management of high flow VMs, hot water proves to be 
more efficacious in terms of (a) a rapid onset of action, 
which is heat dependent endothelial damage, thus 
promoting instant intralesional coagulation; (b) 
minimum collateral damage as the hot water quickly 
loses heat on injection into the lesion and the damage 
due to the outflow from the lesion is minimal [29]. 
However, due to limited necrosing property of hot 
water, its use as a standalone therapy in management 
of such lesions may inefficacious, coupled with the fact 
that the high flow VMs tend to quickly develop collateral 
circulation on disruption of flow through the lesion.  
In this study, the five patients in whom the VMs 
were larger and deep-seated, with high flow 
characteristics as demonstrated by Doppler 
examinations, (placed in Group B), were managed 
using hot water injection into the lesion, followed by 
surgical excision later. Sclerotherapy alone would not 
have sufficed, as there was a need for a more 
encompassing technique that would not only collapse 
and obliterate the abnormal blood vessels to avoid 
undue hemorrhage, but also extirpate the residual 
fibrosed tissues. Two hot water injections were given 
over a period of 24 hours and the lesion was surgically 
removed within 72 hours of initiation of therapy. All 
these five cases were those of high flow VMs involving 
the facial and / or lingual artery. There was complete 
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Table 1: Patient Details Including Clinical Features, Treatment Carried out and Post-Operative Results 
Age/ 
Gender Site & Extent of Lesion Clinical Features Inv Diag 
Treatment Carried 
Out 
Follow up / 
Recurrence 
1. 
32/F 
Right buccal mucosa & 
vestibule extending 
anteriorly upto the angle 
of the mouth and 
posteriorly upto the 
second molar region; 
reflecting superiorly into 
the alveolar and gingival 
mucosa of the right upper 
posterior quadrant. 
Well demarcated and distinct, 
bluish purple patch, with 
scattered elevated deep red 
speckled spots giving the 
lesion a pebbled appearance. 
Persisted throughout 
childhood, adolescence and 
adulthood, without any rapid 
increase or decrease in its 
size. Occasional pain and 
recurrent episodes of bleeding 
from the region. 
Doppler, TBC, 
PT, PTTK-MB, 
INR 
Low flow VM 
Single session 
sclerotherapy using 
3cc of Polydocanol 
injected 
transmucosally into 
sides and center of 
lesion. 
3 Yrs. No 
recurrence 
2. 
45/M 
Right side of the nose, 
extending from the bridge 
halfway down to the ala, 
and from nasolabial fold 
to the midline. 
Longstanding, painless, well 
demarcated raised, deep 
purplish lesion with a pebbly 
texture which blanched on 
pressure. Present since 
childhood, slowly increasing in 
size over the years. It bled 
profusely on occasions. 
Doppler, TBC, 
PT, PTTK-MB, 
INR 
Low flow VM 
Single session 
percutaneous injection 
of 2cc Polydocanol 
into the sides as well 
as center of lesion  
2 Yrs. No 
recurrence 
3. 
35/F 
Vermilion of Upper lip. 
A longstanding outgrowth on 
the upper lip, 0.5X0.5cm in 
size, which bled repeatedly on 
minor trauma. 
TBC, PT, 
PTTK-MB, INR Low flow VM 
Single session 
percutaneous injection 
of 2cc Polydocanol in 
center of lesion 
1 Yr. No 
recurrence 
4. 
42/F 
Right submandibular 
region 
Painless, pulsatile, soft 
swelling, 1.0X2X1.8cm in size, 
present since childhood and 
gradually increasing in size. 
Multiple arterial and venous 
channels noted within the 
region on USG.  
USG, CT 
angiography, 
OPG, TBC, PT, 
PTTK, INR 
High Flow 
VM involving 
the facial 
artery 
Sclerothrombosis 
using hot water x 2 
cycles followed by 
surgical excision via 
submandibular 
approach 
3 Yrs Diffuse 
recurrence 
noted in the 
3rd yr. Slower 
growth.  
5. 
28/F 
Right Infraorbital region 
Longstanding, diffuse, 
painless, soft pulsatile 
swelling,  
CT 
angiography, 
OPG, TBC, PT, 
PTTK, INR  
High Flow 
VM involving 
the facial 
artery 
Sclerothrombosis 
using hot water x 2 
cycles followed by 
surgical excision using 
submandibular 
approach 
3 Yrs. No 
recurrence  
6. 
29/F 
Lower labial mucosa, from 
one corner of the mouth 
to the other, extending 
down to the depth of the 
labial vestibule. 
Deep bluish-purple raised 
patch, with distinct margins. 
Longstanding, present since 
childhood, slowly increasing in 
size, with a recent sudden 
spurt in growth corresponding 
with the beginning of use of 
Oral contraceptives by the 
patient. 
Doppler, TBC, 
PT, PTTK-MB, 
INR 
Low flow VM 
Single session 
sclerotherapy using 
3cc of Polydocanol 
injected permucosally 
into sides and center 
of lesion. 
3 Yrs. No 
recurrence 
7. 
31/F 
Rt preauricular region, 
3cm in diameter 
Painless, mildly raised, 
purplish patch with a grainy 
texture, blanching on pressure. 
Present since infancy, 
persisting into adolescence 
and adulthood, increase in 
size commensurate with 
growth of the patient. 
Doppler, TBC, 
PT, PTTK-MB, 
INR 
Low flow VM 
Single session 
percutaneous injection 
of 2cc Polydocanol 
into the sides as well 
as center of lesion 
1 yr. No 
recurrence 
8.  
45/F 
Left submandibular region 
Painless, pulsatile, soft 
swelling, 2.0x2x1.5cm in size, 
present since childhood and 
gradually increasing in size. 
Multiple arterial and venous 
channels noted within the 
region on USG. 
USG, CT 
angiography, 
OPG, TBC, PT, 
PTTK, INR 
High Flow 
VM involving 
the facial and 
lingual 
arteries  
Sclerothrombosis 
using hot water x 2 
cycles followed by 
surgical excision via 
visor approach i.e. 
Risdon’s along with 
submandibular 
approach  
5 yrs. Nil 
recurrence 
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9. 
32/F 
Lower Lip 
Painless, bulbous, warm, soft 
swelling, 3.0x2x1.5cm in size, 
present since childhood, 
showing a recent increase in 
size over the past six months, 
following the use of Oral 
contraceptives.  
USG, CT 
angiography, 
OPG, TBC, PT, 
PTTK, INR 
High Flow 
VM involving 
the Facial 
and labial 
arteries. 
Sclerothrombosis 
using hot water x 2 
cycles followed by 
surgical excision. 
3 yrs. Nil 
recurrence 
10. 55/M Upper Lip 
Painless, pulsatile, soft 
swelling, 1.0x2x1.5cm in size, 
present since childhood, 
increasing with advancing age. 
USG, CT 
angiography, 
OPG, TBC, PT, 
PTTK, INR 
High Flow 
VM involving 
the labial 
artery. 
Sclerothrombosis 
using hot water x 2 
cycles followed by 
surgical excision. 
3 yrs. Nil 
recurrence 
 
resolution of all the five lesions, except for one which 
showed a mild recurrence after two years.  
CONCLUSION 
Based on our experience we conclude that 
Sclerotherapy, which is a relatively simple, 
conservative and inexpensive therapy, can be safely 
and effectively used in superficial low flow lesions of 
the maxillofacial region. For patients with larger, deep-
seated and high flow vascular malformations, 
intralesional sclerothrombosis using hot water in two 
cycles followed by surgical excision within 72 hours of 
the intralesional therapy is recommended as a 
definitive treatment, having proved to be effective in 
management of such lesions, without the need of any 
sophisticated equipment. However, considering the 
challenging and ominous nature of these lesions, larger 
studies may be undertaken to corroborate these 
findings and employ it as an established protocol. 
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